| ¡ Regístrese ahora en R3i! JW Eikelboom, SJ Connolly, J Bosch | | |
| ‘Real world’use of non-vitamin K antagonist oral anticoagulants (NOACs): Lessons from the Dresden NOAC Registry JW Eikelboom, JI Weitz Thrombosis and haemostasis 113 (06), 1159-1161, 2015 | 24 | 2015 |
| 'Reversible nature of platelet binding causing transfusion-related acute lung injury (TRALI) syndrome may explain dyspnea after ticagrelor and elinogrel'–a hypothesis that … K Schrör Thrombosis and haemostasis 108 (12), 1028-1030, 2012 | 2 | 2012 |
| " Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin: Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY … JS Healey, J Eikelboom, S Yang, E Themeles, SJ Connolly, S Yusuf, ... Circulation 127 (11), E506-E506, 2013 | | 2013 |
| 023 Risk Stratification Using CHA2DS2-VASc and CHADS2 Scores in Patients With Chronic Atherosclerotic Cardiovascular Disease Receiving Aspirin With or Without Rivaroxaban: An … J Sen, A Tonkin, J Varigos, S Fonguh, S Berkowitz, S Yusuf, P Verhamme, ... Heart, Lung and Circulation 29, S48, 2020 | | 2020 |
| 11 Thrombolytic Therapy for Deep Vein Thrombosis and Pulmonary Embolism SJ McRae, JW Eikelboom Evidence-Based Hematology, 88, 2009 | | 2009 |
| 12-month post-trial follow-up of participants in the Australian arm of the second low-dose colchicine trial SM Nidorf, C Budgeon, JW Eikelboom, K Murray, L Nidorf, PL Thompson, ... European Heart Journal 42 (Supplement_1), ehab724. 1254, 2021 | 1 | 2021 |
| 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation developed … Authors/Task Force Members, AJ Camm, GYH Lip, R De Caterina, ... European heart journal 33 (21), 2719-2747, 2012 | 6547 | 2012 |
| 2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Task Force on Expert … GF Tomaselli, KW Mahaffey, A Cuker, PP Dobesh, JU Doherty, ... Journal of the American College of Cardiology 70 (24), 3042-3067, 2017 | 619 | 2017 |
| 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight … GF Tomaselli, KW Mahaffey, A Cuker, PP Dobesh, JU Doherty, ... JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 77 (21), 2634-2634, 2021 | | 2021 |
| 2020 Asian Pacific Society of Cardiology Consensus Recommendations on antithrombotic management for high-risk chronic coronary syndrome JWC Tan, DP Chew, D Brieger, J Eikelboom, G Montalescot, J Ako, ... European Cardiology Review 16, 2021 | 8 | 2021 |
| 2051 A meta-analysis of INR targets for mechanical heart valves: we need new evidence S Gupta, E Belley-Cote, A Sarkaria, A Pandey, G McClure, I Jaffer, ... European Heart Journal 38 (suppl_1), ehx502. 2051, 2017 | 1 | 2017 |
| 2180 Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial TI De Vries, JW Eikelboom, J Bosch, J Westerink, JAN Dorresteijn, ... European Heart Journal 40 (Supplement_1), ehz748. 0099, 2019 | | 2019 |
| 262 Initial Experience With Idarucizumab in Dabigatran-Treated Patients Presenting With Acute Traumatic Injuries: Interim Results From the RE-VERSE AD Study CV Pollack, F Gruenenfelder, J Eikelboom, E Hylek, M Mills, F Sellke, ... Annals of Emergency Medicine 66 (4), S94, 2015 | | 2015 |
| 287 Diabetes mellitus is a risk factor for ischemic stroke in patients with and without coronary artery disease after coronary angiography KKW Olesen, M Madsen, C Gyldenkerne, PG Thrane, M Wurtz, T Thim, ... European Heart Journal 40 (Supplement_1), ehz747. 0091, 2019 | 1 | 2019 |
| 288 Thrombotic events in bleeding patients treated with andexanet alpha: an ANNEXA-4 sub-study J Beyer-Westendorf, P Yue, M Crowther, JW Eikelboom, CM Gibson, ... European Heart Journal 40 (Supplement_1), ehz747. 0092, 2019 | | 2019 |
| 2ème Newsletter 2020, le 28 octobre 2020 SM Nidorf, ATL Fiolet, A Mosterd, JW Eikelboom, A Schut, TSJ Opstal | | |
| 331 Distribution of response to clopidogrel therapy using vasodilator stimulated phosphoprotein assay in patients undergoing primary percutaneous coronary intervention for ST … J Paikin, JW Eikelboom, S Brons, MJ Rokoss, N Valettas, JL Velianou, ... Canadian Journal of Cardiology 5 (27), S182-S183, 2011 | | 2011 |
| 4 Initial Experience With Idarucizumab in Dabigatran-Treated Patients Presenting With Acute Gastrointestinal Hemorrhage: Interim Results from the RE-VERSE AD Study CV Pollack, F Gruenenfelder, J Eikelboom, E Hylek, M Mills, M Huisman, ... Annals of Emergency Medicine 66 (4), S2-S3, 2015 | 2 | 2015 |
| 4112 Risk factors and clinical outcomes in chronic CAD and PAD: an analysis of the randomized, double-blind COMPASS trial T Vanassche, P Verhamme, S Anand, J Bosch, J Eikelboom European Heart Journal 40 (Supplement_1), ehz745. 0116, 2019 | | 2019 |
Graeme J. HankeyPerron Institute Chair in Stroke Research, The University of Western Australia在 uwa.edu.au 的电子邮件经过验证
